Boston Scientific BSX · USD
Health Care · Health Care Equipment & Supplies · US listing · 🇺🇸 United States
S&P 500
44.02
+2.97%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Boston Scientific
From its filings with the US Securities and Exchange Commission
Boston Scientific is based in Marlborough, Massachusetts and is incorporated in Delaware. Its shares trade on NYSE under the ticker BSX. It is a member of the S&P 500. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 December 2025, it reported revenue of $20.07bn and net income of $2.89bn. At that date it held total assets of $43.67bn and shareholders' equity of $24.23bn.
We expect to continue to invest in our core businesses and pursue opportunities to diversify and further expand our presence in strategic, high-growth adjacencies and new global markets, including growth within the countries we define as emerging markets. Maintaining and expanding our international presence is an important component of our long-term growth strategy. Through our international presence, we seek to increase net sales and market share, leverage our relationships with leading physicians and their clinical research programs, accelerate the time to bring new products to market and gain access to worldwide technological developments that we can implement across our product lines. Our research and development efforts are focused largely on the development of next-generation and novel technology offerings across multiple programs and all divisions. In the past several years, we have completed numerous acquisitions in support of our growth strategy, both strengthening our core businesses and expanding into high growth adjacent markets. We continue to develop digital tools and technologies that enable us to compete more effectively and deliver first class remote physician education, drive deeper patient engagement and increase digitally-enabled sales force productivity.
Quoted from its 10-K, filed 17 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 19 May 1992
- Employees
- 59,000
- Website
- bostonscientific.com ↗
- Head office
- 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA, 01752-1234
- Incorporated in
- DE
- Classification
- Surgical & Medical Instruments & Apparatus
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Mr. Michael MahoneyChairman of the Board, President, Chief Executive Officer, since 2011$21.4m
- Mr. Jonathan MonsonChief Financial Officer, Executive Vice President
- Ms. Miriam O' SullivanChief Human Resources Officer, Senior Vice President
- Mr. Arthur ButcherExecutive Vice President, Group President, MedSurg and Asia Pacific$5.0m
- Mr. Joseph FitzgeraldExecutive Vice President, Group President - Cardiology$6.3m
- Mr. Jeffrey MirvissExecutive Vice President and President - Peripheral Interventions$4.0m
- Mr. John SorensonExecutive Vice President - Global Operations
- Mr. Vance BrownSenior Vice President, General Counsel, Corporate Secretary
- Mr. Michael JonesSenior Vice President and President - Endoscopy
- Mr. Scott OlsonSenior Vice President, President - Cardiac Rhythm Management and Diagnostics
- Ms. Meghan ScanlonSenior Vice President and President - Urology
- Mr. Edward LudwigLead Independent Director$376,667
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 71
- Environment
- 56
- Social
- 94
- Governance
- 63
- Direct emissions (scope 1)
- 87,567 t
- Energy emissions (scope 2)
- 112,861 t
- Value chain emissions (scope 3)
- 2,035,890 t
- Women in the workforce
- 49.9%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Boston Scientific Corp has a strong portfolio of innovative medical devices and technologies that cater to a wide range of medical specialties.
- The company has a global presence and operates in over 130 countries, providing access to a large customer base and potential for market expansion.
- Boston Scientific Corp has a solid reputation for delivering high-quality products and services, leading to strong customer loyalty and trust.
Weaknesses
- One of the weaknesses for Boston Scientific Corp is its dependence on third-party suppliers for certain critical components, which makes the company vulnerable to supply chain disruptions.
- The company has faced challenges related to regulatory compliance, which can impact its ability to introduce new products and comply with changing market requirements.
- Boston Scientific Corp operates in a highly competitive market, which puts pressure on pricing and profit margins.
Opportunities
- The growing global healthcare market presents opportunities for Boston Scientific Corp to expand its customer base and increase sales.
- Advancements in medical technology and increased adoption of minimally invasive procedures create opportunities for the company to develop and introduce new innovative products.
- Expansion into emerging markets, such as Asia and Latin America, offers the potential for significant revenue growth for Boston Scientific Corp.
Threats
- Intense competition from other medical device companies poses a threat to Boston Scientific Corp's market share and profitability.
- Changes in healthcare regulations and policies can impact the pricing and reimbursement of medical devices, posing challenges to the company's financial performance.
- Fluctuating currency exchange rates can affect Boston Scientific Corp's international operations and profitability.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.